المؤلفون: L. Johnetta Blakely, Sabine Oskar, Ian Kudel, Ashley Roush, Zoya Shamsi, Toni Perry, Annette Christianson, Brittni Smith, Thomas Burke

المصدر: Journal of Comparative Effectiveness Research, Vol 14, Iss 2 (2025)

مصطلحات موضوعية: electronic patient-reported outcomes, healthcare resource use, non-small-cell lung cancer, noona, observational study, real-world time on treatment, real-world time to next treatment or death, standard of care, symptoms, Public aspects of medicine, RA1-1270

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2042-6313

URL الوصول: https://doaj.org/article/5f0af3111a96462280b6fc5eec3dba89

المؤلفون: Shirish M. Gadgeel, Pragya Rai, Srinivas Annavarapu, Sartaj Alam, Jerome H. Goldschmidt, Howard (Jack) West, Melissa Santorelli, Renata Eiras Martins

المصدر: Frontiers in Oncology, Vol 14 (2024)

مصطلحات موضوعية: non-small cell lung cancer, pembrolizumab monotherapy, overall survival, real-world time on treatment, reasons for discontinuation, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fonc.2024.1298603/full; https://doaj.org/toc/2234-943X

URL الوصول: https://doaj.org/article/9b3a9a0770cd434b8b46c82596f9dd6b

المؤلفون: Marina C. Garassino, MD, Sabine Oskar, PhD, MPH, Ashwini Arunachalam, MPH, BDS, Ke Zu, PhD, ScD, MPH, Yu-Han Kao, PhD, Cai Chen, PhD, Weilin Meng, MEng, M. Catherine Pietanza, MD, Bin Zhao, MD, Himani Aggarwal, MPhil, PhD

المصدر: JTO Clinical and Research Reports, Vol 4, Iss 10, Pp 100568- (2023)

مصطلحات موضوعية: Advanced non–small cell lung cancer, Genomic alterations, Immunotherapy, Real-world time on treatment, Real-world time to next treatment, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S266636432300111X; https://doaj.org/toc/2666-3643

URL الوصول: https://doaj.org/article/1969648679be4785880ac7e95d565f5e

المؤلفون: Stephen V. Liu, MD, Pragya Rai, PhD, Dong Wang, PhD, Xiaohan Hu, PhD, MPH, Paul Otto Schwarzenberger, MD

المصدر: JTO Clinical and Research Reports, Vol 4, Iss 2, Pp 100444- (2023)

مصطلحات موضوعية: (Nab-)paclitaxel, Pembrolizumab, Real-world time on treatment, Squamous cell carcinoma, Survival, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2666364322001680; https://doaj.org/toc/2666-3643

URL الوصول: https://doaj.org/article/baf2b5b2f56343278829f47207d9116b

المؤلفون: Shirish M. Gadgeel, Pragya Rai, Srinivas Annavarapu, Sartaj Alam, Jerome H. Goldschmidt, Howard, Melissa Santorelli, Renata Eiras Martins

مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, non-small cell lung cancer, pembrolizumab monotherapy, overall survival, real-world time on treatment, reasons for discontinuation

Relation: https://figshare.com/articles/dataset/DataSheet_1_Frontline_pembrolizumab_monotherapy_for_metastatic_non-small_cell_lung_cancer_with_PD-L1_expression_50_real-world_outcomes_in_a_US_community_oncology_setting_docx/25368175

الاتاحة: https://doi.org/10.3389/fonc.2024.1298603.s001